A citation-based method for searching scientific literature

Gabriel G Gamber, Erik Meredith, Qingming Zhu, Wanlin Yan, Chang Rao, Michael Capparelli, Robin Burgis, Istvan Enyedy, Ji-Hu Zhang, Nicolas Soldermann, Kimberley Beattie, Olga Rozhitskaya, Keith A Koch, Nikos Pagratis, Vinayak Hosagrahara, Richard B Vega, Timothy A McKinsey, Lauren Monovich. Bioorg Med Chem Lett 2011
Times Cited: 25

List of shared articles

Times cited

A targeted library screen reveals a new inhibitor scaffold for protein kinase D.
Manuj Tandon, Lirong Wang, Qi Xu, Xiangqun Xie, Peter Wipf, Qiming Jane Wang. PLoS One 2012

Protein kinase D isoforms: new targets for therapy in invasive breast cancers?
Sahra Borges, Peter Storz. Expert Rev Anticancer Ther 2013

Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity.
Elizabeth R Sharlow, Gabriela Mustata Wilson, David Close, Stephanie Leimgruber, Manuj Tandon, Robyn B Reed, Tong Ying Shun, Q Jane Wang, Peter Wipf, John S Lazo. PLoS One 2011

Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
Kara M George, Marie-Céline Frantz, Karla Bravo-Altamirano, Courtney R Lavalle, Manuj Tandon, Stephanie Leimgruber, Elizabeth R Sharlow, John S Lazo, Q Jane Wang, Peter Wipf. Pharmaceutics 2011

Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.
Xuejing Zhang, Jaclyn Connelly, Yapeng Chao, Qiming Jane Wang. Biomolecules 2021

Protein kinase D signaling in cancer: A friend or foe?
Adhiraj Roy, Jing Ye, Fan Deng, Qiming Jane Wang. Biochim Biophys Acta Rev Cancer 2017

SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest.
Manuj Tandon, Joseph M Salamoun, Evan J Carder, Elisa Farber, Shuping Xu, Fan Deng, Hua Tang, Peter Wipf, Q Jane Wang. PLoS One 2015

Protein kinase d as a potential chemotherapeutic target for colorectal cancer.
Ning Wei, Edward Chu, Peter Wipf, John C Schmitz. Mol Cancer Ther 2014

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors.
Philippe Gilles, Rudra S Kashyap, Maria João Freitas, Sam Ceusters, Koen Van Asch, Anke Janssens, Steven De Jonghe, Leentje Persoons, Mathias Cobbaut, Dirk Daelemans,[...]. Eur J Med Chem 2020

Protein kinase D2: a versatile player in cancer biology.
Ninel Azoitei, Mathias Cobbaut, Alexander Becher, Johan Van Lint, Thomas Seufferlein. Oncogene 2018

The oncogenic role of protein kinase D3 in cancer.
Yan Liu, Hang Song, Yehui Zhou, Xinxing Ma, Jing Xu, Zhenghong Yu, Liming Chen. J Cancer 2021

Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.
Nisha Durand, Sahra Borges, Peter Storz. Cell Mol Life Sci 2015

Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer.
Yan Liu, Hang Song, Shiyi Yu, Kuo-Hsiang Huang, Xinxing Ma, Yehui Zhou, Shuang Yu, Jingzhong Zhang, Liming Chen. J Cell Mol Med 2020

Unveiling the Structural Insights into the Selective Inhibition of Protein Kinase D1.
Raju Dash, Md Arifuzzaman, Sarmistha Mitra, Md Abdul Hannan, Nurul Absar, S M Zahid Hosen. Curr Pharm Des 2019

New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells.
Manuj Tandon, James Johnson, Zhihong Li, Shuping Xu, Peter Wipf, Qiming Jane Wang. PLoS One 2013